HAE · NYSE · CIK 0000313143

HAEMONETICS CORP

HAEMONETICS CORP’s most recent SEC filing in our snapshot is a Form 8-K filed on Oct 8, 2026. In fiscal 2026 (year ended Mar 28, 2026) it reported revenue of $1.3B and net income of $97.3M, according to its XBRL data on EDGAR. Its EDGAR record lists 20 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2026
$1.3B
Net income, FY2026
$97.3M
Form 4 filings on record, past 12 months
20

Company overview

Legal name (as filed)
HAEMONETICS CORP
Ticker
HAE
SEC Central Index Key (CIK)
0000313143
Business address
BOSTON, MA
State or country of incorporation
MA
Fiscal year ends
April 3
SEC filer category
Large accelerated filer
Position in SEC ticker list
#1299 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from HAEMONETICS CORP’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$993.2MFY2022$1.2BFY2023$1.3BFY2024$1.4BFY2025$1.3BFY2026
Net income
$43.4MFY2022$115.4MFY2023$117.6MFY2024$167.7MFY2025$97.3MFY2026
HAE annual results
ItemFY2022
ended Apr 2, 2022		FY2023
ended Apr 1, 2023		FY2024
ended Mar 30, 2024		FY2025
ended Mar 29, 2025		FY2026
ended Mar 28, 2026
Revenue$993.2M$1.2B$1.3B$1.4B$1.3B
Net income$43.4M$115.4M$117.6M$167.7M$97.3M
Diluted EPS$0.84$2.24$2.29$3.31$2.05
Total assets$1.9B$1.9B$2.2B$2.5B$2.4B
Cash and equivalents$259.5M$284.5M$178.8M$306.8M$245.4M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashAndCashEquivalentsAtCarryingValue. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

HAE latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
May 20, 202610-KAnnual report· period Mar 28, 2026Document · Index
Aug 6, 202610-QQuarterly report· period Jun 27, 2026Document · Index
Oct 8, 20268-KRegulation FD disclosure· period Oct 8, 2026Document · Index
Jun 9, 2026DEF 14ADefinitive proxy statement· period Mar 28, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about HAEMONETICS CORP, by form type:

4 ×188-K ×8SCHEDULE 13G/A ×3SCHEDULE 13G ×33 ×1S-8 ×110-Q ×1ARS ×1DEFA14A ×1DEF 14A ×1SD ×110-K ×1
HAE recent filings
FiledFormWhat it isOriginal
Oct 8, 20268-KRegulation FD disclosure· period Oct 8, 2026Document · Index
Aug 18, 20268-KRegulation FD disclosure· period Aug 18, 2026Document · Index
Aug 12, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Aug 6, 2026S-8Registration of employee benefit plan securitiesDocument · Index
Aug 6, 202610-QQuarterly report· period Jun 27, 2026Document · Index
Aug 6, 20268-KResults of operations· period Aug 6, 2026Document · Index
Jul 28, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 24, 2026Document · Index
Jul 28, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 24, 2026Document · Index
Jul 28, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 24, 2026Document · Index
Jul 28, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 24, 2026Document · Index
Jul 28, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 24, 2026Document · Index
Jul 28, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 24, 2026Document · Index
Jul 28, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 24, 2026Document · Index
Jul 28, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 24, 2026Document · Index
Jul 28, 20263Initial statement of beneficial ownership· period Jul 24, 2026Document · Index
Jul 28, 20268-KDirector or officer change; Shareholder vote results· period Jul 24, 2026Document · Index
Jun 9, 2026ARSARS· period Mar 28, 2026Document · Index
Jun 9, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Jun 9, 2026DEF 14ADefinitive proxy statement· period Mar 28, 2026Document · Index
Jun 8, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 5, 2026Document · Index
Jun 8, 20264Statement of changes in beneficial ownership (insider trade)· period Jun 5, 2026Document · Index
Jun 5, 20268-KRegulation FD disclosure· period Jun 5, 2026Document · Index
May 28, 2026SDSpecialized disclosure report (conflict minerals)Document · Index
May 20, 202610-KAnnual report· period Mar 28, 2026Document · Index
May 19, 20264Statement of changes in beneficial ownership (insider trade)· period May 15, 2026Document · Index
May 19, 20264Statement of changes in beneficial ownership (insider trade)· period May 15, 2026Document · Index
May 19, 20264Statement of changes in beneficial ownership (insider trade)· period May 15, 2026Document · Index
May 19, 20264Statement of changes in beneficial ownership (insider trade)· period May 15, 2026Document · Index
May 19, 20264Statement of changes in beneficial ownership (insider trade)· period May 15, 2026Document · Index
May 19, 20264Statement of changes in beneficial ownership (insider trade)· period May 15, 2026Document · Index
May 19, 20264Statement of changes in beneficial ownership (insider trade)· period May 15, 2026Document · Index
May 13, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
May 7, 20268-KResults of operations· period May 7, 2026Document · Index
May 5, 20264Statement of changes in beneficial ownership (insider trade)· period May 1, 2026Document · Index
May 1, 20268-KDirector or officer change· period Apr 27, 2026Document · Index
Apr 30, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Apr 29, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Mar 27, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Mar 3, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Mar 3, 20268-KRegulation FD disclosure· period Mar 3, 2026Document · Index

Insider filing activity

20 Form 4 filings appear in HAEMONETICS CORP’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Surgical & Medical Instruments & Apparatus

All 51 companies in Surgical & Medical Instruments & Apparatus· Companies headquartered in Massachusetts

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0000313143 and XBRL company facts. HAEMONETICS CORP on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.